Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia [Phase 3]
Phase 3 clinical trial evaluating substitution of atazanavir (with or without ritonavir boosting) for ritonavir-boosted protease inhibitors …
-
FDA approval · 2011-07-18FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved Cosette Pharmaceuticals' supplemental application for Welchol (colesevelam hydrochloride).
-
CLINICAL_TRIALS trial_result · 2011-07-18Clinical Trial Update: Red Yeast Rice and Phytosterols In Statin Intolerance [Phase 2, Phase 3]
This clinical trial update concerns the use of red yeast rice and phytosterols for statin-intolerant patients with hyperlipidemia. The Phase…
-
CLINICAL_TRIALS trial_result · 2011-07-06Clinical Trial Update: The Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood Glucose [NA]
Clinical trial update on Hypocol's effects on lipids in people with mild hypercholesterolemia and mildly elevated blood glucose.
-
CLINICAL_TRIALS trial_result · 2011-07-01Clinical Trial Update: The Effect of Q10 and Selen Supplement on Muscular Adverse Events in Statin Therapy [Phase 4]
A Phase 4 clinical trial evaluated whether Coenzyme Q10 and selenium supplementation influence muscular adverse events in patients taking st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-07-01Clinical Trial Update: Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of pitavastatin and atorvastatin in high-risk hyperlipidemic patients; the status of the …
-
FDA approval · 2011-06-27FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved a supplemental application for fenofibrate from Amneal Pharmaceuticals NY LLC under the ANDA. The approval confirms changes…
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume [Phase 4]
Phase 4 clinical trial update evaluating rosuvastatin’s effect on reducing coronary atherosclerosis plaque volume in patients with hyperlipi…
-
FDA approval · 2011-06-17FDA Approved: LESCOL XL — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for LESCOL XL (fluvastatin sodium) submitted by Sandoz Inc.
-
FDA approval · 2011-06-16FDA Approved: LIVALO — Supplemental Application (Kowa Pharmaceuticals America, Inc.)
FDA approves a supplemental application for LIVALO (pitavastatin calcium) submitted by Kowa Pharmaceuticals America. The approval expands th…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia [Phase 3]
Phase 3 study evaluating the efficacy and safety of topiramate in obese adults with dyslipidemia. The trial was terminated.
-
FDA approval · 2011-05-08FDA Approved: FENOFIBRATE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
The FDA approved a supplemental application for fenofibrate (generic) from Rhodes Pharmaceuticals L.P., granting approval for an ANDA-relate…
-
FDA approval · 2011-03-14FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for fenofibric acid submitted by Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2011-03-10Clinical Trial Update: Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart Disease [Phase 4]
Phase 4 clinical trial evaluating the effect of fenofibrate on endothelial function and HDL in patients with coronary heart disease and hype…
-
FDA approval · 2011-02-22FDA Approved: SIMVASTATIN — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for Accord Healthcare's generic simvastatin (SIMVASTATIN), enabling its marketing as a generic stati…
-
FDA approval · 2011-02-16FDA Approved: GEMFIBROZIL — Supplemental Application (Northstar RxLLC)
FDA approved a supplemental application for gemfibrozil submitted by Northstar RxLLC under an ANDA.
-
CLINICAL_TRIALS trial_result · 2011-02-10Clinical Trial Update: Efficacy of Laflavon in Lowering Triglycerides and Raising High-Density Lipoprotein (HDL) [Phase 3]
Phase 3 clinical trial evaluating Laflavon for lowering triglycerides and increasing HDL; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2011-01-06Clinical Trial Update: Influence of Organic Anion Transporting Polypeptide1B1(OATP1B1) Genotype on Rosuvastatin PK, PD and Lipid Profiles [Phase 4]
Phase 4 trial update examining how OATP1B1 genotype influences rosuvastatin pharmacokinetics, pharmacodynamics, and lipid responses.
-
CLINICAL_TRIALS trial_result · 2010-12-30Clinical Trial Update: Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease [Phase 2]
Phase 2 trial update evaluating proteinuria and renal function in non-diabetic patients with progressive renal disease has completed, with r…
-
CLINICAL_TRIALS research · 2010-12-23Clinical Trial Update: Jiangzhuo Prescription ，Fenofibrate and Placebo in the Treatment of Hyperlipidemia (Syndrome of Phlegm Obstruction)Clinical Study (JZF)
This is a clinical trial update comparing Jiangzhuo Prescription, Fenofibrate, and a placebo for hyperlipidemia and metabolic syndrome, spon…
-
CLINICAL_TRIALS research · 2010-12-13Clinical Trial Update: Association of Genetic Polymorphisms With Lipid Lowering Effects of Statin Therapy
This clinical trial investigates how genetic polymorphisms influence the lipid-lowering response to statin therapy.
-
CLINICAL_TRIALS research · 2010-12-03Clinical Trial Update: To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia
A completed clinical trial explored the treatment effects of various commercially available statins in patients with hyperlipidemia.
-
CLINICAL_TRIALS research · 2010-11-09Clinical Trial Update: A Study Using L5 as a Risk Factor of Cardiovascular (CV) Disease in Chronic Renal and Dialytic Patients
A clinical trial update examining L5 as a risk factor for cardiovascular disease in patients with chronic kidney disease and those on dialys…
-
CLINICAL_TRIALS trial_result · 2010-11-04Clinical Trial Update: Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels
An observational study on adherence to statin therapy in patients with high cholesterol (dyslipidemia) completed, with results posted in 201…
-
FDA approval · 2010-09-20FDA Approved: SIMVASTATIN — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for simvastatin from Accord Healthcare, Inc. (ANDA 078155).